Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 5/20 | 0.77 |
| ▸ | HTR2A | P28223 | 5/20 | 0.77 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.57 |
| ▸ | CASR | P41180 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23694369 | 1.00 | CYP2D6 (0.77) | CYP2D6HTR2AABCB1CASR | |
| SCHEMBL23694371 | 1.00 | CYP2D6 (0.77) | CYP2D6HTR2AABCB1CASR | |
| SCHEMBL8703542 | 0.93 | CYP2D6 (0.67) | CYP2D6HTR2AABCB1CASR | |
| Hydrochloric Acid SCHEMBL8701977 | 0.92 | CYP2D6 (0.66) | CYP2D6HTR2AABCB1CASR | |
| SCHEMBL30001633 | 0.89 | CYP2D6 (0.74) | CYP2D6HTR2AABCB1 | |
| SCHEMBL10805464 | 0.89 | CYP2D6 (0.74) | CYP2D6HTR2AABCB1 | |
| Hydrochloric Acid SCHEMBL10806395 | 0.87 | CYP2D6 (0.72) | CYP2D6HTR2AABCB1 | |
| SCHEMBL19900842 | 0.87 | CYP2D6 (1.00) | CYP2D6HTR2AABCB1 | |
| SCHEMBL19350963 | 0.87 | CYP2D6 (1.00) | CYP2D6HTR2AABCB1 | |
| SCHEMBL30416731 | 0.87 | CYP2D6 (1.00) | CYP2D6HTR2AABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210228508-A1 | COMPOSITIONS AND METHODS THEREOF | Exciva GmbH | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228508-A1 | COMPOSITIONS AND METHODS THEREOF | CYP21A2, CYP2C19, CYP2F1 | CYP2D6 7/4885HTR2A 1705/4885ABCB1 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.